Prevention of treatment of bone loss in premenopausal women

[Guest guest]

" While there is little information on the prevention or treatment of

bone loss in premenopausal women, these women, too, may lose bone mass

if they are being treated with glucocorticoids, so prevention of bone

loss with antiresorptive agents should be considered. If bisphosphonate

therapy is being considered for a premenopausal woman, she must be

counseled regarding use of appropriate contraception.

The therapies to prevent or treat glucocorticoid-induced bone loss

should be continued as long as the patient is receiving glucocorticoids.

Data from large studies of anabolic agents (e.g., parathyroid hormone)

and further studies of combination therapy in patients receiving

glucocorticoids are eagerly awaited so additional options will be

available for the prevention of this serious complication of

glucocorticoid treatment. "

National Guideline Clearinghouse

" Recommendations for the prevention and treatment of glucocorticoid

induced osteoporosis " :

http://www.guideline.gov/summary/summary.aspx?doc_id=2934

I'll tell you where to go!

Mayo Clinic in Rochester

http://www.mayoclinic.org/rochester

s Hopkins Medicine

http://www.hopkinsmedicine.org